Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50


Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects.

Al Qarni AA, Joatar FE, Das N, Awad M, Eltayeb M, Al-Zubair AG, Ali ME, Al Masaud A, Shire AM, Gumaa K, Giha HA.

Endocrinol Metab (Seoul). 2017 Jun;32(2):230-240. doi: 10.3803/EnM.2017.32.2.230. Epub 2017 May 29.


Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.

Edgerton DS, Kraft G, Smith M, Farmer B, Williams PE, Coate KC, Printz RL, O'Brien RM, Cherrington AD.

JCI Insight. 2017 Mar 23;2(6):e91863. doi: 10.1172/jci.insight.91863.


Finding the right route for insulin delivery - an overview of implantable pump therapy.

Bally L, Thabit H, Hovorka R.

Expert Opin Drug Deliv. 2017 Sep;14(9):1103-1111. doi: 10.1080/17425247.2017.1267138. Epub 2016 Dec 7. Review.


Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a review.

Achong N, McIntyre HD, Callaway L.

Obstet Med. 2014 Jun;7(2):52-9. doi: 10.1177/1753495X13516442. Epub 2014 Jan 17. Review.


Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.

Sheikh S, Gudipaty L, De Leon DD, Hadjiliadis D, Kubrak C, Rosenfeld NK, Nyirjesy SC, Peleckis AJ, Malik S, Stefanovski D, Cuchel M, Rubenstein RC, Kelly A, Rickels MR.

Diabetes. 2017 Jan;66(1):134-144. doi: 10.2337/db16-0394. Epub 2016 Aug 5.


Relationship between Body Mass Index, C-Peptide, and Delta-5-Desaturase Enzyme Activity Estimates in Adult Males.

Pickens CA, Matsuo KH, Fenton JI.

PLoS One. 2016 Mar 29;11(3):e0149305. doi: 10.1371/journal.pone.0149305. eCollection 2016.


Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans.

Pal A, Potjer TP, Thomsen SK, Ng HJ, Barrett A, Scharfmann R, James TJ, Bishop DT, Karpe F, Godsland IF, Vasen HF, Newton-Bishop J, Pijl H, McCarthy MI, Gloyn AL.

Diabetes. 2016 Feb;65(2):527-33. doi: 10.2337/db15-0602. Epub 2015 Nov 5.


Effect of dietary fructose on portal and systemic serum fructose levels in rats and in KHK-/- and GLUT5-/- mice.

Patel C, Sugimoto K, Douard V, Shah A, Inui H, Yamanouchi T, Ferraris RP.

Am J Physiol Gastrointest Liver Physiol. 2015 Nov 1;309(9):G779-90. doi: 10.1152/ajpgi.00188.2015. Epub 2015 Aug 27.


Physiological effects and therapeutic potential of proinsulin C-peptide.

Yosten GL, Maric-Bilkan C, Luppi P, Wahren J.

Am J Physiol Endocrinol Metab. 2014 Dec 1;307(11):E955-68. doi: 10.1152/ajpendo.00130.2014. Epub 2014 Sep 23. Review.


Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.

Gudipaty L, Rosenfeld NK, Fuller CS, Gallop R, Schutta MH, Rickels MR.

Diabetes Care. 2014 Sep;37(9):2451-8. doi: 10.2337/dc14-0398. Epub 2014 Jun 26.


Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.

Edgerton DS, Moore MC, Winnick JJ, Scott M, Farmer B, Naver H, Jeppesen CB, Madsen P, Kjeldsen TB, Nishimura E, Brand CL, Cherrington AD.

Diabetes. 2014 Nov;63(11):3946-54. doi: 10.2337/db14-0266. Epub 2014 Jun 19.


The therapeutic potential of C-peptide in kidney disease: a protocol for a systematic review and meta-analysis.

Shaw J, Shetty P, Burns K, Knoll G.

Syst Rev. 2014 May 2;3:43. doi: 10.1186/2046-4053-3-43. Review.


A single-blind, placebo-controlled, dose-ranging trial of oral hepatic-directed vesicle insulin add-on to oral antidiabetic treatment in patients with type 2 diabetes mellitus.

Geho WB, Rosenberg LN, Schwartz SL, Lau JR, Gana TJ.

J Diabetes Sci Technol. 2014 May;8(3):551-9. doi: 10.1177/1932296814524871. Epub 2014 Feb 27.


Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.

Sheldon RD, Laughlin MH, Rector RS.

J Appl Physiol (1985). 2014 May 1;116(9):1156-64. doi: 10.1152/japplphysiol.01275.2013. Epub 2014 Feb 27.


Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development.

Hemer S, Konrad C, Spiliotis M, Koziol U, Schaack D, Förster S, Gelmedin V, Stadelmann B, Dandekar T, Hemphill A, Brehm K.

BMC Biol. 2014 Jan 27;12:5. doi: 10.1186/1741-7007-12-5.


Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes.

Richards JP, Stephenson AH, Ellsworth ML, Sprague RS.

Am J Physiol Regul Integr Comp Physiol. 2013 Dec;305(11):R1331-6. doi: 10.1152/ajpregu.00341.2013. Epub 2013 Oct 2.


C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat.

Flynn ER, Lee J, Hutchens ZM Jr, Chade AR, Maric-Bilkan C.

J Diabetes Complications. 2013 Nov-Dec;27(6):538-47. doi: 10.1016/j.jdiacomp.2013.07.002. Epub 2013 Aug 29.


Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.

Edgerton DS, An Z, Johnson KM, Farmer T, Farmer B, Neal D, Cherrington AD.

Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E132-9. doi: 10.1152/ajpendo.00160.2013. Epub 2013 May 14.


C-peptide as a remedy for diabetic microangiopathy?

Waldhäusl W.

Diabetes. 2013 Jan;62(1):39-40. doi: 10.2337/db12-1250. No abstract available.


Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog.

Ramnanan CJ, Kraft G, Smith MS, Farmer B, Neal D, Williams PE, Lautz M, Farmer T, Donahue EP, Cherrington AD, Edgerton DS.

Diabetes. 2013 Jan;62(1):74-84. doi: 10.2337/db12-0148. Epub 2012 Sep 25.

Supplemental Content

Support Center